Junwen Wang, Yuyang Ye, Xuefeng Chen, Xinru Hu, Yong Peng
{"title":"高血压患者便秘和心血管死亡风险:一项长期队列研究","authors":"Junwen Wang, Yuyang Ye, Xuefeng Chen, Xinru Hu, Yong Peng","doi":"10.1155/ijhy/9921027","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Whether constipation serves as a risk factor for mortality in hypertensive patients remains an open question. The purpose of the study was to investigate the association of constipation in hypertensive patients with the prognosis for mortality. <b>Methods:</b> The study utilized data from the National Health and Nutrition Examination Survey (NHANES) conducted in 2009-2010 involving hypertensive individuals. Constipation was self-reported over the past 12 months. Cox regression analyses, adjusted for age, sex, and race/ethnicity, were employed to assess the association between constipation and all-cause mortality, as well as cardiovascular mortality. Subgroup and sensitivity analyses were conducted to explore variations in the relationship across different demographic and comorbidity groups. <b>Results:</b> Of the 5199 individuals, 1285 had constipation. Hypertensive patients with constipation exhibited an increased risk of all-cause mortality (HR, 1.40, 95% CI, 0.99 to 1.97, <i>p</i>=0.06) and cardiovascular mortality (HR, 1.83, 95% CI, 1.09 to 3.07, <i>p</i>=0.02) compared to nonconstipated patients. The Kaplan-Meier survival curves also reflected higher rates of all-cause mortality (92.71% vs. 89.18%, <i>p</i> < 0.001) and cardiovascular mortality (97.87% vs. 96.44%, <i>p</i>=0.004) in the constipation group. Among hypertensive patients with a PIR ≤ 100, those with constipation exhibited significantly higher all-cause mortality risk than those without (HR 1.95; 95% CI 1.14-2.67; <i>p</i> < 0.001). These patients also demonstrated increased cardiovascular mortality risk (HR 1.93; 95% CI 1.12-3.40; <i>p</i>=0.019). <b>Conclusion:</b> Constipation shows a significant association with increased cardiovascular mortality risk in hypertensive patients.</p>","PeriodicalId":14132,"journal":{"name":"International Journal of Hypertension","volume":"2025 ","pages":"9921027"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12490922/pdf/","citationCount":"0","resultStr":"{\"title\":\"Constipation and Cardiovascular Mortality Risk in Patients With Hypertension: A Long-Term Cohort Study.\",\"authors\":\"Junwen Wang, Yuyang Ye, Xuefeng Chen, Xinru Hu, Yong Peng\",\"doi\":\"10.1155/ijhy/9921027\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Whether constipation serves as a risk factor for mortality in hypertensive patients remains an open question. The purpose of the study was to investigate the association of constipation in hypertensive patients with the prognosis for mortality. <b>Methods:</b> The study utilized data from the National Health and Nutrition Examination Survey (NHANES) conducted in 2009-2010 involving hypertensive individuals. Constipation was self-reported over the past 12 months. Cox regression analyses, adjusted for age, sex, and race/ethnicity, were employed to assess the association between constipation and all-cause mortality, as well as cardiovascular mortality. Subgroup and sensitivity analyses were conducted to explore variations in the relationship across different demographic and comorbidity groups. <b>Results:</b> Of the 5199 individuals, 1285 had constipation. Hypertensive patients with constipation exhibited an increased risk of all-cause mortality (HR, 1.40, 95% CI, 0.99 to 1.97, <i>p</i>=0.06) and cardiovascular mortality (HR, 1.83, 95% CI, 1.09 to 3.07, <i>p</i>=0.02) compared to nonconstipated patients. The Kaplan-Meier survival curves also reflected higher rates of all-cause mortality (92.71% vs. 89.18%, <i>p</i> < 0.001) and cardiovascular mortality (97.87% vs. 96.44%, <i>p</i>=0.004) in the constipation group. Among hypertensive patients with a PIR ≤ 100, those with constipation exhibited significantly higher all-cause mortality risk than those without (HR 1.95; 95% CI 1.14-2.67; <i>p</i> < 0.001). These patients also demonstrated increased cardiovascular mortality risk (HR 1.93; 95% CI 1.12-3.40; <i>p</i>=0.019). <b>Conclusion:</b> Constipation shows a significant association with increased cardiovascular mortality risk in hypertensive patients.</p>\",\"PeriodicalId\":14132,\"journal\":{\"name\":\"International Journal of Hypertension\",\"volume\":\"2025 \",\"pages\":\"9921027\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12490922/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Hypertension\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/ijhy/9921027\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/ijhy/9921027","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
背景:便秘是否作为高血压患者死亡的危险因素仍然是一个悬而未决的问题。本研究的目的是探讨高血压患者便秘与死亡预后的关系。方法:本研究利用2009-2010年国家健康与营养调查(NHANES)中高血压患者的数据。便秘是在过去12个月内自我报告的。采用Cox回归分析,调整年龄、性别和种族/民族,评估便秘与全因死亡率以及心血管死亡率之间的关系。进行了亚组和敏感性分析,以探索不同人口统计学和合并症组之间关系的变化。结果:在5199人中,1285人有便秘。与非便秘患者相比,高血压合并便秘患者的全因死亡率(HR, 1.40, 95% CI, 0.99 ~ 1.97, p=0.06)和心血管死亡率(HR, 1.83, 95% CI, 1.09 ~ 3.07, p=0.02)增加。Kaplan-Meier生存曲线也反映出便秘组的全因死亡率(92.71%比89.18%,p < 0.001)和心血管死亡率(97.87%比96.44%,p=0.004)较高。在PIR≤100的高血压患者中,便秘患者的全因死亡风险明显高于无便秘患者(HR 1.95; 95% CI 1.14-2.67; p < 0.001)。这些患者还表现出心血管死亡风险增加(HR 1.93; 95% CI 1.12-3.40; p=0.019)。结论:便秘与高血压患者心血管死亡风险增加有显著关联。
Constipation and Cardiovascular Mortality Risk in Patients With Hypertension: A Long-Term Cohort Study.
Background: Whether constipation serves as a risk factor for mortality in hypertensive patients remains an open question. The purpose of the study was to investigate the association of constipation in hypertensive patients with the prognosis for mortality. Methods: The study utilized data from the National Health and Nutrition Examination Survey (NHANES) conducted in 2009-2010 involving hypertensive individuals. Constipation was self-reported over the past 12 months. Cox regression analyses, adjusted for age, sex, and race/ethnicity, were employed to assess the association between constipation and all-cause mortality, as well as cardiovascular mortality. Subgroup and sensitivity analyses were conducted to explore variations in the relationship across different demographic and comorbidity groups. Results: Of the 5199 individuals, 1285 had constipation. Hypertensive patients with constipation exhibited an increased risk of all-cause mortality (HR, 1.40, 95% CI, 0.99 to 1.97, p=0.06) and cardiovascular mortality (HR, 1.83, 95% CI, 1.09 to 3.07, p=0.02) compared to nonconstipated patients. The Kaplan-Meier survival curves also reflected higher rates of all-cause mortality (92.71% vs. 89.18%, p < 0.001) and cardiovascular mortality (97.87% vs. 96.44%, p=0.004) in the constipation group. Among hypertensive patients with a PIR ≤ 100, those with constipation exhibited significantly higher all-cause mortality risk than those without (HR 1.95; 95% CI 1.14-2.67; p < 0.001). These patients also demonstrated increased cardiovascular mortality risk (HR 1.93; 95% CI 1.12-3.40; p=0.019). Conclusion: Constipation shows a significant association with increased cardiovascular mortality risk in hypertensive patients.
期刊介绍:
International Journal of Hypertension is a peer-reviewed, Open Access journal that provides a forum for clinicians and basic scientists interested in blood pressure regulation and pathophysiology, as well as treatment and prevention of hypertension. The journal publishes original research articles, review articles, and clinical studies on the etiology and risk factors of hypertension, with a special focus on vascular biology, epidemiology, pediatric hypertension, and hypertensive nephropathy.